Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Kapoor

Showing results (1-10 of 394) with videos related to

Pageof 40
Sort By:
British Journal of Haematology|November 6, 2024
Checkpoint inhibition in macroglobulinaemiaPrashant Kapoor
British Journal of Haematology|July 13, 2019
The MYD88<sup>L265P</sup> conundrum in IgM monoclonal gammopathy of undetermined significancePrashant Kapoor
Blood|January 28, 2017
Another bidder (BDR) revisitsPrashant Kapoor
The Lancet. Oncology|September 16, 2021
Daratumumab for post-ASCT maintenance treatment of myelomaPrashant Kapoor, Shaji Kumar
Cancer Treatment and Research Communications|February 12, 2022
Current approach to Waldenström MacroglobulinemiaGayathri Ravi, Prashant Kapoor
Journal of the National Comprehensive Cancer Network : JNCCN|September 5, 2024
Diagnosis and Risk Stratification in Waldenström MacroglobulinemiaSaurabh Zanwar, Prashant Kapoor
International Journal of Hematology|October 19, 2011
Update on risk stratification and treatment of newly diagnosed multiple myelomaPrashant Kapoor, S Vincent Rajkumar
Current Hematologic Malignancy Reports|July 6, 2024
Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström MacroglobulinemiaKaran L Chohan, Prashant Kapoor
Blood|October 29, 2020
The race to stymie BTK: zanu zingsPrashant Kapoor, Steven P Treon
JACC. Cardiooncology|October 10, 2022
Cardiovascular Associations With Monoclonal Gammopathy of Undetermined Significance: Real or Coincidental?Prashant Kapoor, S Vincent Rajkumar
Pageof 40

Showing results (1-10 of 394) with videos related to

Sort By:
Pageof 40
British Journal of Haematology|November 6, 2024
Checkpoint inhibition in macroglobulinaemiaPrashant Kapoor
British Journal of Haematology|July 13, 2019
The MYD88<sup>L265P</sup> conundrum in IgM monoclonal gammopathy of undetermined significancePrashant Kapoor
Blood|January 28, 2017
Another bidder (BDR) revisitsPrashant Kapoor
The Lancet. Oncology|September 16, 2021
Daratumumab for post-ASCT maintenance treatment of myelomaPrashant Kapoor, Shaji Kumar
Cancer Treatment and Research Communications|February 12, 2022
Current approach to Waldenström MacroglobulinemiaGayathri Ravi, Prashant Kapoor
Journal of the National Comprehensive Cancer Network : JNCCN|September 5, 2024
Diagnosis and Risk Stratification in Waldenström MacroglobulinemiaSaurabh Zanwar, Prashant Kapoor
International Journal of Hematology|October 19, 2011
Update on risk stratification and treatment of newly diagnosed multiple myelomaPrashant Kapoor, S Vincent Rajkumar
Current Hematologic Malignancy Reports|July 6, 2024
Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström MacroglobulinemiaKaran L Chohan, Prashant Kapoor
Blood|October 29, 2020
The race to stymie BTK: zanu zingsPrashant Kapoor, Steven P Treon
JACC. Cardiooncology|October 10, 2022
Cardiovascular Associations With Monoclonal Gammopathy of Undetermined Significance: Real or Coincidental?Prashant Kapoor, S Vincent Rajkumar
Pageof 40